Interview, Podcast
The chips are down: will diet drugs devour junk food?
- Global dementia case numbers are projected to grow sharply due to rapid global aging, with age-related incidence expected to decline in Western Europe and North America but rise in nations like Japan and China as diets deteriorate.
- Approximately 45% of dementia cases may be preventable or delayable through lifestyle changes, though governments face significant hurdles in implementing national plans given widespread past failures in production and execution.
- The food industry is expected to introduce new product categories addressing weight loss drugs and ultra-processed food concerns, though historical reliance on reducing salt, sugar, and fat remains the primary strategic focus.
- Consumer preference for established treats like Mars bars and sugary cereals suggests these products will persist despite health awareness, with junk food sales anticipated to grow by an average of 5% year-on-year.
- Morgan Stanley forecasts that 7% to 9% of Americans will use weight loss drugs by 2035, potentially causing a marginal drop in total U.S. calorie intake and altering population consumption patterns.
- Nestlé has targeted a 50% sales increase for more nutritious products by the end of this decade, a goal expected to materialize gradually rather than instantaneously.
- Food companies are predicted to adapt to emerging trends by creating targeted products for specific consumer bases, similar to historical responses to diet fads, though the long-term viability of eliminating sugary products remains uncertain.